OrthoPediatrics Corp. marks a significant advancement in treatment options for Early Onset Scoliosis patients under the age of 10 with the VerteGlide™ Spinal Growth Guidance System. This innovative medical device represents the company’s 80th pediatric orthopedic solution and addresses critical limitations in current Early Onset Scoliosis treatments. It was developed in collaboration with leading pediatric spine surgeons including Dr. Richard McCarthy and Dr. Scott Luhmann. According to the brand, its product can potentially reduce the frequency of invasive surgical interventions required during a child’s skeletal development.

The design of the VerteGlide™ Spinal Growth Guidance System focuses on gradual deformity correction while accommodating natural growth patterns. This is a crucial consideration for young patients whose bodies continue developing post-treatment. The technology builds upon licensed Shilla™ platform elements.

Image Credit: OrthoPediatrics Corp.